A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …
Human safety, tolerability, and pharmacokinetics of molnupiravir, a novel broad-spectrum oral antiviral agent with activity against SARS-CoV-2
WP Painter, W Holman, JA Bush… - Antimicrobial agents …, 2021 - Am Soc Microbiol
Molnupiravir (EIDD-2801/MK-4482), the prodrug of the active antiviral ribonucleoside analog
β-d-N4-hydroxycytidine (NHC; EIDD-1931), has activity against a number of RNA viruses, …
β-d-N4-hydroxycytidine (NHC; EIDD-1931), has activity against a number of RNA viruses, …
Molnupiravir, an oral antiviral treatment for COVID-19
Background Easily distributed oral antivirals are urgently needed to treat coronavirus
disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of severe …
disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of severe …
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
…, E Adams, K Bullock, W Holman… - Journal of …, 2021 - academic.oup.com
Objectives AGILE is a Phase Ib/IIa platform for rapidly evaluating COVID-19 treatments. In
this trial (NCT04746183) we evaluated the safety and optimal dose of molnupiravir in …
this trial (NCT04746183) we evaluated the safety and optimal dose of molnupiravir in …
[HTML][HTML] Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo …
…, M Jacobs, J Northey, W Painter, W Holman… - The Lancet Infectious …, 2023 - thelancet.com
Background The antiviral drug molnupiravir was licensed for treating at-risk patients with
COVID-19 on the basis of data from unvaccinated adults. We aimed to evaluate the safety and …
COVID-19 on the basis of data from unvaccinated adults. We aimed to evaluate the safety and …
Complex angular momenta and the groups SU (1, 1) and SU (2)
WJ Holman III, LC Biedenharn Jr - Annals of Physics, 1966 - Elsevier
The Wigner coefficients coupling any two discrete representations of the noncompact group
SU(1, 1) are derived, and it is shown that they can be expressed as analytic continuations of …
SU(1, 1) are derived, and it is shown that they can be expressed as analytic continuations of …
[HTML][HTML] Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2
W Holman, W Holman, S McIntosh, W Painter… - Trials, 2021 - Springer
A recently published article described the safety, tolerability, and pharmacokinetic profile of
molnupiravir (Painter et al. 2021), a novel antiviral agent with potent activity against severe …
molnupiravir (Painter et al. 2021), a novel antiviral agent with potent activity against severe …
Summation Theorems for Hypergeometric Series in
WJ Holman III - SIAM Journal on Mathematical Analysis, 1980 - SIAM
Explicit expressions for the matrix elements of multiplicity-free Wigner and Racah coefficients
in $U(n)$ are used to establish multidimensional analogs of known hypergeometric …
in $U(n)$ are used to establish multidimensional analogs of known hypergeometric …
Modified Isobar Approximation for Scattering
WJ Holman III - Physical Review, 1965 - APS
The equations for the scattering amplitude for three pions in a J= 1−, T= 0 state, subject to
the approximation of elastic unitarity, are formulated in accordance with the ND method. It is …
the approximation of elastic unitarity, are formulated in accordance with the ND method. It is …
Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in nonplasma compartments of patients with severe acute respiratory …
…, H Reynolds, W Painter, W Holman… - Clinical Infectious …, 2022 - academic.oup.com
ß-d-N4-hydroxycytidine (NHC), the parent nucleoside of molnupiravir, a COVID-19 antiviral,
was quantified at SARS-CoV-2 transmission sites in 12 patients enrolled in AGILE Candidate…
was quantified at SARS-CoV-2 transmission sites in 12 patients enrolled in AGILE Candidate…
